Praxis Precision Medicines Inc Live Stock Price Today, Share Analysis and Chart

Name: Praxis Precision Medicines Inc: Is Infosys Ltd. worth buying?
Item: Praxis Precision Medicines Inc
Rating: 2.01041675
Author: Trendlyne DVM scores

about

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...

179.07 0.99 (0.56%)

570.67% Gain from 52W Low

15,973

XNAS Volume

XNAS 14 Nov, 2025 9:38 AM (EST)

Board Meeting

The next board meeting for Praxis Precision Medicines Inc is on 18 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

3.2 / 100

Technically Bullish

77.3 / 100

315

1Yr Price target upside is 76%

14 analysts

Praxis Precision Medicines Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Praxis Precision Medicines Inc Live Stock Price Today, Share Analysis and Chart

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal ...

570.67% Gain from 52W Low

SWOT Analysis

Praxis Precision Medicines Inc Live Price Chart